Juan Carlos
Martínez Castrillo
Profesor/a Asociado/a en CC. de la Salud
Araceli
Alonso Cánovas
Profesor/a Asociado/a en CC. de la Salud
Publicacions en què col·labora amb Araceli Alonso Cánovas (44)
2024
-
Concomitant treatment with safinamide and antidepressant drugs: Safety data from real clinical practice
Neurologia, Vol. 39, Núm. 4, pp. 340-344
2023
-
Cognitive impairment and dementia in young onset Parkinson’s disease
Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812
-
Functional movement disorder comorbidity in Parkinson's disease: A multicenter descriptive study
Parkinsonism and Related Disorders
-
Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: A national multicentre observational study
Journal of Neurology, Neurosurgery and Psychiatry
-
Switching from Rasagiline to Safinamide as an Add-On Therapy Regimen in Patients with Levodopa: A Literature Review
Brain Sciences, Vol. 13, Núm. 2
-
¿Qué piensan los estudiantes de Medicina sobre los trastornos neurológicos funcionales?
Revista de neurologia, Vol. 76, Núm. 8, pp. 265-271
2022
-
Efficacy and safety of high doses of safinamide in advanced Parkinson disease
Parkinsonism and Related Disorders
-
Eye-of-the-Tiger Sign with an Unexpected Pathological Diagnosis
Movement Disorders Clinical Practice, Vol. 9, Núm. 1, pp. 98-103
2021
-
Apomorphine: A powerful ally in parkinson's disease
Revista de Neurologia, Vol. 72, Núm. 9, pp. 323-332
-
COVID-19 in Parkinson’s disease: what holds the key?
Journal of Neurology, Vol. 268, Núm. 8, pp. 2666-2670
-
Does the Country Make a Difference in Impulse Control Disorders? A Systematic Review
Movement Disorders Clinical Practice, Vol. 8, Núm. 1, pp. 25-32
-
Impact of SAfinamide on depressive symptoms in parkinson’s disease patients (SADness-PD Study): A multicenter retrospective study
Brain Sciences, Vol. 11, Núm. 2, pp. 1-11
-
Impulse Control Disorders in Parkinson's Disease: Has COVID-19 Related Lockdown Been a Trigger?
Movement Disorders Clinical Practice, Vol. 8, Núm. 6, pp. 940-943
-
Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1
Neurologia, Vol. 36, Núm. 2, pp. 149-158
-
Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2
Neurologia, Vol. 36, Núm. 2, pp. 159-168
-
Mutational spectrum of GNAL, THAP1 and TOR1A genes in isolated dystonia: study in a population from Spain and systematic literature review
European Journal of Neurology, Vol. 28, Núm. 4, pp. 1188-1197
-
Predictors of clinically significant quality of life impairment in Parkinson’s disease
npj Parkinson's Disease, Vol. 7, Núm. 1
2020
-
Clinical experience in the treatment of motor fluctuations in Parkinson's disease. Delphi consensus of a group of experts in movement disorders
Revista de Neurologia, Vol. 71, Núm. 11, pp. 407-420
-
Effects of Motor Symptom Laterality on Clinical Manifestations and Quality of Life in Parkinson's Disease
Journal of Parkinson's Disease, Vol. 10, Núm. 4, pp. 1611-1620
-
Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort
Scientific Reports, Vol. 10, Núm. 1